Indian Pharma Sector Growth in FY27

The Indian pharmaceutical sector is expected to grow steadily in the next fiscal year, mainly because more people in India are buying medicines and there's more work in making medicines for other countries.

The domestic market is expected to grow by 12.7%, and the part of the business that makes medicines for others is expected to grow by 9.9%.

However, the business in the US is expected to shrink by 9.3% because of a strong previous performance.

The sector is also facing higher costs for things like shipping and power, which might reduce profits.

There's also some uncertainty because one company stopped making a certain medicine due to quality issues.

Overall, the sector is expected to recover in the long term.